Omeprazole Mobius Healthcare (Omeprazole)

Omeprazole acts on the gastric acid‑secretion pathway and is indicated for several gastrointestinal conditions.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal erosion.
• Peptic ulcer disease: accelerates ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production.
• NSAID‑induced ulcer prevention: lowers the incidence of ulcer formation in patients on non‑steroidal anti‑inflammatory drugs.
• Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

• Omeprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acidity, allowing mucosal healing and symptom control.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient.
• Nausea: occasional and mild.
• Abdominal pain: cramp‑like discomfort.
• Flatulence: increased gas.
• Constipation: infrequent.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fracture risk: especially with long‑term use.
• Vitamin B12 deficiency: anemia, neuropathy.
• Liver enzyme elevation: jaundice, dark urine.

Omeprazole should be used with consideration of the following precautions.

• Pregnancy: discuss risks with a healthcare professional; limited data available.
• Breastfeeding: assess benefit‑risk ratio before use.
• Renal impairment: monitor renal function in severe cases.
• Hepatic impairment: dose adjustment may be required for severe liver disease.
• Long‑term therapy: evaluate need periodically to avoid potential nutrient deficiencies.
• Drug interactions: review concomitant medications for possible interactions.
• Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atazanavir: markedly decreased absorption, loss of antiviral efficacy.
• Methotrexate (high dose): increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, monitor coagulation parameters.
• Digoxin: modest increase in serum levels, watch for toxicity signs.
• Phenytoin: decreased serum concentration, may require dose adjustment.
• Ketoconazole/Itraconazole: reduced antifungal absorption, consider alternative therapy.